ABSTRACT2,3,7,8,-Tetrachlorodibenzo-p-dioxin (TCDD) administered in vivo causes drastic reduction in the weight of the mouse thymus at low doses (e.g., 30 pg/kg single i.p. i jection), the reduction becoming statistically significant after 2 days. To understand the cause for such thymic involution TCDD-evoked changes in various biochemical parameters in this tissue were examined. The most noticeable change was observed in the increased activity of specific protein-tyrosine kinases and protein kinase C and an increased level of p21-associated binding of [3H]GTP. Since no significant change was observed with cAMP-stimulated protein kinases and cAMP levels, the above changes appear to be a selective effect on these special classes of proteins. As a result of a time sequence study it has become apparent that the rise in proteintyrosine kinase activities becomes significant within 24 hr, whereas the rise in protein kinase C does not become sicant until 48 hr. Among protein-tyrosine kinases, pp60c-and probably pps6lskT were found to be significantly elevated by TCDD treatment. In view of similarities between TCDD and thyroid hormones in causing thymic involution, the levels of c-erb-A expression were assessed in the liver by using avian 32P-labeled v-erb-A probe and RNA transfer blot hybridization technique. The results clearly indicate that TCDD has the property to elevate levels of mRNA bearing homology to v-erb-A. Such changes in c-erb-A expression and proteintyrosine kinase occurred only in TCDD-susceptible (responsive) strains but not in tolerant (nonresponsive) strains of mice at the dose tested. Based on such observations a hypothesis has been proposed that TCDD owes its potency to its ability to stimulate the expression of one of a family of DNAs bearing homology to v-erb-A and that one of the major consequences of such an action is stimulation of various tyrosine kinases.2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a very toxic, teratogenic, and carcinogenic chemical (1-4). In addition to these deleterious effects, TCDD is known to cause atrophy of thymus (5, 6) in most experimental animals. Since this lesion occurs at sublethal doses of TCDD at an early stage of poisoning, it has been used by several scientists (e.g., refs. 2, 7, 8) as a sensitive indicator of TCDD poisoning.As for the possible cause for such a thymic lesion, Neal et al. (9) have shown that an increase in serum glucocorticoid levels is unlikely. Poland and Glover (7) have found that involution of thymus occurs at low doses of TCDD (30 ,ug/ kg) in sensitive (responsive) strains of mice but only at high doses in tolerant (nonresponsive) strains of mice. These workers used such differential responses among mouse strains as a biochemical indicator for the involvement of specific cytosolic TCDD binding proteins (i.e., TCDD receptor) in the final expression of thymic involution.Our research group has been studying the effects of TCDD on the hepatic plasma membrane receptors. To date, the plasma membrane-bound epidermal growth factor (EGF) r...